Pacira BioSciences Newsroom

H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $39

Futu NewsDec 6 00:36

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $39 Price Target

BenzingaDec 4 19:29

Pacira BioSciences Analyst Ratings

BenzingaDec 4 19:26

Pacira BioSciences Price Target Cut to $17.00/Share From $25.00 by Barclays

Dow JonesNov 12 23:13

Pacira BioSciences Is Maintained at Equal-Weight by Barclays

Dow JonesNov 12 23:13

Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 8 04:31

Pacira BioSciences Analyst Ratings

BenzingaNov 8 01:32

RBC Capital Adjusts Price Target on Pacira Biosciences to $16 From $15, Maintains Sector Perform Rating

MT NewswiresNov 7 22:35

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating

Futu NewsNov 7 22:35

H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $39

Futu NewsNov 7 19:31

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating

Futu NewsOct 22 19:31

RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15

BenzingaOct 4 23:55

Pacira BioSciences Analyst Ratings

BenzingaOct 4 23:54

Jefferies Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Cuts Target Price to $18

Futu NewsSep 24 21:32

Jefferies & Co Adjusts Pacira BioSciences Price Target to $18 From $15, Maintains Buy Rating

MT NewswiresSep 24 21:14

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:42

Pacira BioSciences Analyst Ratings

BenzingaAug 13 22:03

Truist Financial Downgrades Pacira BioSciences(PCRX.US) to Sell Rating, Announces Target Price $8

Futu NewsAug 13 18:31

Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30

MT NewswiresAug 13 18:25

Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25

Futu NewsAug 13 17:33